mometasone furoate long acting (LYR-220) / Lyra Therap - LARVOL DELTA

Evaluation of LYR-220 Mometasone Sinonasal Implants in Patients With Chronic Rhinosinusitis and Prior Ethmoid Surgery: Results From the Randomized, Blinded, Controlled BEACON Phase 2 Study. (PubMed, Int Forum Allergy Rhinol) - "The BEACON study demonstrated safety, efficacy, feasibility, and tolerability of LYR-220 in patients with CRS who have had prior ESS. The primary endpoint was met, with no SAEs reported. LYR-220 demonstrated statistically significant, clinically relevant improvements in key symptomatic and objective efficacy endpoints."

Journal • P2 data • Inflammation • Otorhinolaryngology • Pain • Respiratory Diseases • Sinusitis

LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study) (clinicaltrials.gov) - P2 | N=50 | Completed | Sponsor: Lyra Therapeutics | Active, not recruiting ➔ Completed

Trial completion • Otorhinolaryngology • Respiratory Diseases • Sinusitis

LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study) (clinicaltrials.gov) - P2 | N=50 | Active, not recruiting | Sponsor: Lyra Therapeutics | Recruiting ➔ Active, not recruiting

Enrollment closed • Otorhinolaryngology • Respiratory Diseases • Sinusitis